Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2681

Actual shortage: 255 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2417 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

38 (15%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2022-12-01 2022-12-15 176776
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2022-12-01 2023-04-28 176779
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2022-12-01 2023-04-28 176794
TEVA-NAPROXEN EC 250MG TABLET (ENTERIC-COATED) Resolved 2023-04-27 2023-06-09 190740
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2023-06-08 2023-06-21 194094
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2023-07-04 2023-07-14 197052
TEVA-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2023-10-05 2023-12-14 206392
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2024-01-11 2024-03-18 215719
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-13 2017-10-10 1748
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-13 2017-10-11 1760
TEVA-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-13 2018-02-21 1769
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-13 2017-10-10 1778
ACT OXYCODONE CR 5MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-17 2017-09-19 3366
ACT OXYCODONE CR 10MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-17 2017-09-19 3377
ACT OXYCODONE CR 20MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-17 2017-07-01 3381
ACT OXYCODONE CR 80MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-17 2017-09-19 3384
TEVA-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2017-04-03 2018-02-21 5223
ACT OXYCODONE CR 40MG TABLET (EXTENDED-RELEASE) Resolved 2017-05-24 2017-09-19 10978
TEVA-METHYLPHENIDATE ER-C 18MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-11-24 2020-01-21 30668
TEVA-METHYLPHENIDATE ER-C 27MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-11-24 2020-01-21 30685

Showing 2541 to 2560 of 2681

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT NABILONE 1MG CAPSULE Discontinued 2019-10-31 2019-11-01 97581
NOVAMOXIN 250MG CAPSULE Discontinued 2020-01-24 2020-01-24 104289
TEVA-QUININE 300MG CAPSULE Discontinued 2020-01-24 2020-01-24 104294
TEVA-TRANDOLAPRIL 0.5MG CAPSULE Discontinued 2020-07-10 2020-07-10 120021
TEVA-TRANDOLAPRIL 1MG CAPSULE Discontinued 2020-07-10 2020-07-10 120024
TEVA-TRANDOLAPRIL 2MG CAPSULE Discontinued 2020-07-10 2020-07-10 120027
TEVA-TRANDOLAPRIL 4MG CAPSULE Discontinued 2020-07-10 2020-07-10 120030
TEVA-PREGABALIN 75MG CAPSULE Discontinued 2020-07-10 2020-07-10 120033
ACT CELECOXIB 100MG CAPSULE To be discontinued 2020-09-03 2020-09-03 123648
ACT CELECOXIB 200MG CAPSULE To be discontinued 2020-09-03 2020-09-03 123651
TEVA-QUININE 200MG CAPSULE Discontinued 2020-10-08 2020-10-09 125976
TEVA-CEPHALEXIN 500MG CAPSULE Discontinued 2020-10-08 2020-10-09 125979
ACT NABILONE 0.5MG CAPSULE Discontinued 2020-10-15 2020-10-15 126452
ACT CELECOXIB 200MG CAPSULE Discontinued 2021-02-12 2021-02-12 133874
ACT CELECOXIB 100MG CAPSULE Discontinued 2021-02-12 2021-02-12 133880
ACT NABILONE 0.5MG CAPSULE Discontinued 2021-09-23 2021-09-23 146066
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Discontinued 2020-06-11 2020-06-11 117491
TEVA-DULOXETINE 60MG CAPSULE (DELAYED RELEASE) Discontinued 2020-06-11 2020-06-11 117494
ACT VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65292
ACT VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65295

Showing 41 to 60 of 250